Alexza Pharmaceuticals Inc.
All Topics
Find news about people
Find news on alumni of any org
Find news on a particular market
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions


Change Feed
Alexza Pharmaceuticals Inc.
... long time and to avoid the first-pass effect in the liver. Alexza Pharmaceuticals Inc. is using its propriety staccato technology for the delivery of its ...
... established benzodiazepine." Engage Therapeutics has an exclusive license and supply agreement with Alexza Pharmaceuticals to develop Staccato alprazolam. This novel drug device combination has been ...
... ADASUVEĀ®, an orally inhaled form of the typical antipsychotic loxapine, from Alexza Pharmaceuticals, Inc. ADASUVE is the first and only FDA-approved inhaled therapy for the ...
... in this Insomnia Pipeline Review, H2 2016 report include Actelion Ltd, Alexza Pharmaceuticals, Inc., Eisai Co., Ltd., Evotec AG, Grupo Ferrer Internacional, S.A., Heptares Therapeutics ...
... Seizures Pipeline Review, H2 2016 report include Adamas Pharmaceuticals, Inc., Advicenne, Alexza Pharmaceuticals, Inc., Biscayne Pharmaceuticals, Inc., Catalyst Pharmaceuticals, Inc., Eisai Co., Ltd., GW Pharmaceuticals ...
... Addex Therapeutics Ltd, Advinus Therapeutics Ltd, Aeolus Pharmaceuticals, Inc., AFFiRiS AG, Alexza Pharmaceuticals, Inc., Amabiotics SAS, Amarantus Bioscience Holdings, Inc., American Gene Technologies International Inc., ...
... Alexza Pharmaceuticals, Inc. ("Alexza" or the "Company") today announced that The Nasdaq Stock Market ...
... TARGET COMPANY: 2264403 Alexza Pharmaceuticals Inc. SELLERS: 2264403 Alexza Pharmaceuticals Inc. ACQUIRER COMPANY: 2428624 Ferrer Pharma Inc. ...
Subscribe now for full coverage on Alexza Pharmaceuticals Inc.
Start My Free Trial